Balyasny Asset Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-30,040	Closed	-$111K	–	2217
2017 Q4	$111K	Buy	30,040 +7,646	+34%	+$28.3K	﹤0.01%	1727
2017 Q3	$92K	Buy	+22,394	New	+$92K	﹤0.01%	1580
2016 Q1	–	Sell	-5,692	Closed	-$76K	–	1451
2015 Q4	$76K	Buy	+5,692	New	+$76K	﹤0.01%	1042